Article
Silencing stomatin-like protein 2 attenuates tumor progression and inflammatory response…
OncoTargets and Therapy · 2019 · Pu X, Dong C, Zhu W, Li W, Jiang H
Key facts
| Title | Silencing stomatin-like protein 2 attenuates tumor progression and inflammatory response through repressing CD14 in liver cancer |
|---|---|
| First author | Pu X, Dong C, Zhu W, Li W, Jiang H |
| Journal | OncoTargets and Therapy |
| Published | Sep 9, 2019 |
| DOI | 10.2147/OTT.S215131 |
| Devices mentioned | 213004, K040782, K973350, K990827 |
| Product codes mentioned | JAK, JLX, KQP |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1